These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 2421887
21. DNA repair and sensitivity of mouse embryo fibroblasts to methyl methanesulphonate and N-methyl-N'-nitro-N-nitrosoguanidine. Anuszewska E, Koziorowska J. Acta Biochim Pol; 1985; 32(4):295-304. PubMed ID: 3832702 [Abstract] [Full Text] [Related]
22. Tumour cell variants with increased immunogenicity obtained by mutagen treatment. Boon T, Maryanski J. Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855 [Abstract] [Full Text] [Related]
23. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens. Yasutake C, Kuratomi Y, Ono M, Masumi S, Kuwano M. Cancer Res; 1987 Sep 15; 47(18):4894-9. PubMed ID: 2441855 [Abstract] [Full Text] [Related]
24. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity. Bai P, Hegedus C, Erdélyi K, Szabó E, Bakondi E, Gergely S, Szabó C, Virág L. Toxicol Lett; 2007 May 15; 170(3):203-13. PubMed ID: 17428624 [Abstract] [Full Text] [Related]
25. Proteomic analysis of cellular responses to low concentration N-methyl-N'-nitro-N-nitrosoguanidine in human amnion FL cells. Jin J, Yang J, Gao Z, Yu Y. Environ Mol Mutagen; 2004 May 15; 43(2):93-9. PubMed ID: 14991749 [Abstract] [Full Text] [Related]
26. Anti-genotoxicity of coffee against N-methyl-N-nitro-N-nitrosoguanidine in mouse lymphoma cells. Abraham SK, Stopper H. Mutat Res; 2004 Jul 11; 561(1-2):23-33. PubMed ID: 15238227 [Abstract] [Full Text] [Related]
27. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT. J Immunol; 1984 Sep 11; 133(3):1664-70. PubMed ID: 6205090 [Abstract] [Full Text] [Related]
28. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein. Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H. Mol Carcinog; 2000 Apr 11; 27(4):298-307. PubMed ID: 10747294 [Abstract] [Full Text] [Related]
29. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models. Brault D, Renault D, Tombolan F, Thybaud V. Environ Mol Mutagen; 1999 Apr 11; 34(2-3):182-9. PubMed ID: 10529742 [Abstract] [Full Text] [Related]
30. Mutational spectra induced under distinct excision repair conditions by the 3 methylating agents N-methyl-N-nitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine and N-nitrosodimethylamine in postmeiotic male germ cells of Drosophila. Nivard MJ, Pastink A, Vogel EW. Mutat Res; 1996 Jun 10; 352(1-2):97-115. PubMed ID: 8676923 [Abstract] [Full Text] [Related]
31. Proteomic analysis of different temporal expression patterns induced by N-methyl-N'-nitro-N-nitrosoguanidine treatment. Shen J, Chen W, Yin X, Yu Y. J Proteome Res; 2008 Jul 10; 7(7):2999-3009. PubMed ID: 18549258 [Abstract] [Full Text] [Related]
32. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N'-nitro-N-nitrosoguanidine. Scudiero DA, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CH, Day RS. Cancer Res; 1984 Mar 10; 44(3):961-6. PubMed ID: 6692418 [Abstract] [Full Text] [Related]
33. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo. Lu LJ, Randerath K. Mol Pharmacol; 1984 Nov 10; 26(3):594-603. PubMed ID: 6208475 [Abstract] [Full Text] [Related]
34. Chemopreventive effects of rofecoxib and folic acid on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. Fei SJ, Xiao SD, Peng YS, Chen XY, Shi Y. Chin J Dig Dis; 2006 Nov 10; 7(3):134-40. PubMed ID: 16808793 [Abstract] [Full Text] [Related]
35. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815. Marchand M, Caspar P, Boon T. Eur J Cancer Clin Oncol; 1983 Nov 10; 19(11):1529-37. PubMed ID: 6196202 [Abstract] [Full Text] [Related]
36. Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation. Simcik W, Frost P, LeGrue SJ. Cancer Res; 1989 Aug 01; 49(15):4192-8. PubMed ID: 2472875 [Abstract] [Full Text] [Related]
37. [Inactivating effect of N-methyl-N'-nitro-N-nitrosoguanidine on yeasts with different ploidies]. Sakovich IS, Efremov BD. Genetika; 1978 Oct 01; 14(10):1834-7. PubMed ID: 363506 [Abstract] [Full Text] [Related]
38. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. Kerbel RS, Frost P, Liteplo R, Carlow DA, Elliott BE. J Cell Physiol Suppl; 1984 Oct 01; 3():87-97. PubMed ID: 6205005 [Abstract] [Full Text] [Related]
39. DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives. Puccetti P, Fuschiotti P, Dominici P, Borri-Voltattorni C, Romani L, Fioretti MC. Int J Cancer; 1987 Jun 15; 39(6):769-73. PubMed ID: 2438236 [Abstract] [Full Text] [Related]
40. Mutagenesis and morphological transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 clone A31-1-1 cell line. Bignami M, Saffiotti U. Carcinogenesis; 1983 Jun 15; 4(4):419-23. PubMed ID: 6839415 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]